Capital Wealth
FRI CLOSE · SEP 25   S&P 500 7,743.41 ▲0.51%  ·  DJIA 51,828.62 ▲0.93%  ·  NASDAQ 27,068.72 ▲0.48%  ·  10-YR 5.17%  ·  2-YR 4.81%  ·  WTI $92.44 ▼2.3%  ·  GOLD $4,320.50 ▲0.5%  ·  VIX 14.87 ▼5.1%
Personal Journal · Health & Safety · M11

Anti-Choking Devices Are Racing the Heimlich Into Schools. The Medical Guidelines Haven’t Signed On

Schools are stocking suction devices and states are weighing mandates. The FDA authorized the leading one in March only as a second-line tool, and the major first-aid guidelines still don’t endorse it.

By Sean Anees Saifi · Capital Wealth · Published Friday, September 25, 2026 · Source: The Wall Street Journal, Thursday, September 24, 2026 edition, whose market figures are the Wednesday, September 23 close (Personal Journal)
Key Points
~5,000
people who die from choking in the U.S. each year
10,000+
LifeVac devices donated to schools
$70M
global revenue LifeVac’s CEO expects this year
22
studies LifeVac cites; too limited, an AHA expert says
A row of empty chairs in a sunlit clinic waiting room beside the reception window.
The Heimlich maneuver is more than 50 years old; the inventor’s son says device makers don’t stress that theirs is only a backup.
In one line: An FDA authorization isn’t a medical recommendation, and the protection the guidelines actually endorse is a trained person, not a device in a drawer.

For more than 50 years, the best-known answer to choking has carried one man’s name. Dr. Henry Heimlich’s technique won its place on simplicity, research and, as Thursday’s Personal Journal notes, the doctor’s own savvy salesmanship. Now it has competition. Advocates, device makers and some politicians contend that the Heimlich and back blows can fall short, and they’re campaigning, online and in statehouses, for portable suction devices that pull a stuck object from the airway.

Under a Texas law passed last year, every school campus must keep at least one device on hand, plus someone on staff who knows how to use it. New York City has a similar law but says it won’t put it into effect unless medical guidelines recommend the devices; bills have been considered in at least nine other states, while pushback has come from state health departments, emergency responders and teachers unions. The leading maker, LifeVac, has given schools more than 10,000 devices and sells a four-device school kit for nearly $280. Its inventor and chief executive, Arthur Lih, expects $70 million in global revenue this year.

Authorized isn’t the same as recommended

In March, LifeVac became the only suction-based anti-choking device authorized by the FDA, and only as a second-line tool for when traditional methods have failed; the agency cautions that grabbing one before the standard steps could slow a rescue. The American Heart Association and the American Red Cross still don’t recommend the devices. “It might work, but we don’t know,” said Dr. Benny Joyner, a pediatrician who co-chairs the AHA’s pediatric basic life-support guidelines. Lih cites 22 independent studies, says LifeVac promotes the device only as a backup and says it offers an option when disability, obesity or pregnancy makes standard methods impractical. A doctor who led one of those studies says the published research rests on case reports, mannequins and cadavers.

About 5,000 people die from choking in the U.S. each year, and it’s one of the leading causes of death in children, who often eat fast and distracted in school lunchrooms. In February, an eight-year-old boy in Manvel, Texas, choked on a grape at school and died. His mother, Kenzie Gray, and accounts of that day say school staff, a nurse among them, and emergency responders tried the Heimlich, a LifeVac, a defibrillator and CPR. LifeVac says it never got confirmation a device was used; the school didn’t comment. Her focus is on training: she wants teachers practiced, in person, in the traditional rescue methods, and she says that kind of training became required at his school only after his death.

Our read

In insurance terms (M11), the skill is the policy and the device is, at most, a rider. The FDA’s own wording says as much: this device is for after the standard methods have failed. So the most useful move for a household isn’t a purchase. It’s a certified first-aid and CPR class through the American Heart Association or the American Red Cross, for parents, grandparents and sitters alike, and following that guidance as it’s updated.

When a safety product is marketed hard and the independent guideline bodies haven’t endorsed it, authorized and recommended are different words for a reason. Read the regulator’s exact language, check what the guidelines say, and let that, not the advertising, decide what earns a place in the drawer. That habit travels well beyond choking devices.

What It Means For Your Portfolio

Hold — take the class; the device is only a backup

No portfolio action. The most valuable safety purchase in this story is a class, not a device: by the FDA’s own terms, the device is only for when the standard methods have already failed.

General planning principles, not advice for anyone in particular. Households insure the big risks and often skip the cheapest protection of all, knowing what to do in the first minutes of an emergency. A certified first-aid and CPR course through the American Heart Association or the American Red Cross, for everyone who feeds the kids, grandparents included, is that protection; follow their guidance rather than a product’s marketing.

The same discipline protects your wallet (M11): when a product leans on a regulator’s authorization, read what the authorization actually says. This one lets LifeVac be used as a second-line tool, which is a long way from a recommendation, and the major guideline bodies haven’t made one.

Book a 15-Minute Review → Back to Edition No. 176 →